Results 221 to 230 of about 770,760 (303)
Political economy of adolescent mental health and well-being globally. [PDF]
Biermann O +17 more
europepmc +1 more source
From disorientation to preparedness: Information practices as scaffolding in acute crises
Abstract This qualitative study examines how adults in Israel enacted information practices during an acute national crisis. Using the information transitions framework, we investigate how concrete practices emerge and evolve across three stages: understanding, negotiating, and resolving. Semi‐structured Zoom interviews with 18 adults were analyzed via
Lilach Alon +2 more
wiley +1 more source
Determinants of sustained physician engagement in obstetric QI: a TICD-guided qualitative study. [PDF]
Sulley S, Kobernik E, Sokol RJ.
europepmc +1 more source
Delineating gender/sex‐related studies through bibliometric analysis
Abstract The multidisciplinary and socially grounded nature of Women's/Gender/Feminist Studies poses unique challenges for bibliometric analysis, as it extends beyond conventional disciplinary boundaries. This paper makes three key contributions: (1) We propose a novel retrieval method for constructing a corpus of scholarly documents in research areas ...
Natsumi S. Shokida +2 more
wiley +1 more source
Rethinking global health financing: from philanthropy to public good. [PDF]
Osborne A.
europepmc +1 more source
Optimizing biomass use for carbon storage and land use with the OptiBiU model
Abstract Optimal biomass use in a circular bioeconomy requires a system perspective to guide decision‐making. The Optimizing Biomass Use (OptiBiU) model was developed for this purpose. The model distinguishes among primary biomass production, intermediate products, and biobased products, and incorporates recycling.
Pim M. Post +8 more
wiley +1 more source
On re-defining public health and making health public. [PDF]
Coggon J.
europepmc +1 more source
Abstract Despite regulatory progress being made in the past two decades, off‐label drug use in paediatrics remains pervasive, with prevalence estimated between 3% and 97% of prescriptions across different clinical settings. Off‐label use—defined as prescribing outside the conditions described in the Summary of Product Characteristics (SmPC)—is often ...
Tjitske M. van der Zanden +3 more
wiley +1 more source
Medical Device Regulation - Who Does the FDA Serve? [PDF]
Moneer O, Rathi V.
europepmc +1 more source
Zuranolone: A case study in (regulatory) rush to judgement?
Abstract Sage, in collaboration with Biogen, submitted a new drug approval for zuranolone for postpartum depression (PPD) and major depressive disorder (MDD) in December 2022. In August 2023, the US Food and Drug Administration granted approval for PPD but denied approval for MDD.
Lisa Cosgrove +4 more
wiley +1 more source

